| CL3145 |
|
257933-82-7 |
(E)-N-[4-[(3-氯-4-氟苯基)氨基]-3-氰基-7-乙氧基-6-喹啉基]-4-(二甲基氨基)-2-丁烯酰胺; 培利替尼; 贝利替尼
Pelitinib (Synonyms: EKB-569; WAY-EKB 569)
-
98+%
|
需询价 |
C24H23ClFN5O2 |
|
|
|
| CL1632A |
|
439081-18-2 |
(S)-N-(4-((3-氯-4-氟苯基)氨基(S)-N-(4-((3-四氢呋喃-3-基)氧基)喹唑啉-6-基)-4-(二甲基氨基)丁-2-烯酰胺
(E/Z)-Afatinib (Synonyms: (E/Z)-BIBW 2992; （S)-阿法替尼)
-
98+%
|
需询价 |
C24H25ClFN5O3 |
|
|
|
| CL3050 |
|
133550-30-8 |
AG490 (Tyrphostin AG490)
AG490 (Synonyms: Tyrphostin AG490; Tyrphostin B42)
-
98+%
|
需询价 |
C17H14N2O3 |
|
|
|
| CL2211A |
|
1421373-66-1 |
迈瑞替尼甲磺酸盐 | 奥希替尼甲磺酸盐
AZD-9291 mesylate | Osimertinib mesylate | Mereletinib mesylate
-
98+%
|
需询价 |
C29H37N7O5S |
|
|
|
| CLA1682 |
|
1826843-81-5 |
德喜曲妥珠单抗 | 德卢替康-曲妥珠单抗
Anti-Human Her2 (Trastuzumab Deruxtecan; T-DXd)
-
98+%
|
需询价 |
— |
|
|
|
| CL2895 |
|
937263-43-9 |
妥卡替尼 | 图卡替尼
Tucatinib | Irbinitinib | ARRY-380 | ONT-380
3-5days
99+%
|
￥436.00 |
C26H24N8O2 |
|
|
|
| CLA1680 |
|
2648260-93-7 |
Becotatug | JMT-101
Becotatug | JMT-101
-
98+%
|
需询价 |
— |
|
|
|
| CL2457 |
|
184475-35-2 |
吉非替尼 | 吉菲替尼
Gefitinib | ZD1839
In-stock
98+%
|
￥166.00 |
C22H24ClFN4O3 |
|
|
|
| CL2423 |
|
183319-69-9 |
盐酸厄洛替尼 | 埃罗替尼盐酸盐
Erlotinib Hydrochloride | Erlotinib HCl
-
98+%
|
需询价 |
C22H23N3O4·HCl |
|
|
|
| CL2220 |
|
231277-92-2 |
拉帕替尼碱 | 拉帕替尼
Lapatinib (GW572016; GW2016,Tykerb, Tyverb)
In-stock
98+%
|
￥580.00 |
C29H26ClFN4O4S |
|
|
|
| CLA1578 |
|
2171511-58-1 |
埃万妥单抗
Anti-Human EGFRxMET Bispecific Antibody(Amivantamab; JNJ-61186372)
-
95+%
|
需询价 |
— |
|
|
|
| CLA1500 |
|
1969309-56-5 |
泽妥珠单抗
Anti-Human Her2xHer3 (Zenocutuzumab; MCLA-128; PB4188; R040517)
-
95+%
|
需询价 |
— |
|
|
|
| CLA1389 |
|
1509928-04-4 |
艾司妥单抗
Anti-Human IGF1RxHer3 Bispecific Antibody (Istiratumab; MM 141; MM-005)
-
95+%
|
需询价 |
— |
|
|
|
| CLA1314 |
|
1310460-86-6 |
扎妥昔单抗
Modotuximab (Anti-ERBB1 / EGFR / HER1)
3-5days
95+%
|
￥4500.00 |
— |
|
|
|
| CLA1304 |
|
959963-46-3 |
伊马曲单抗
Imgatuzumab (Anti-ERBB1 / EGFR / HER1)
3-5days
95+%
|
￥4500.00 |
— |
|
|
|
| CLA1303 |
|
1310460-85-5 |
伏妥昔单抗
Futuximab
3-5days
95+%
|
￥9000.00 |
— |
|
|
|
| CLA1300 |
|
1314238-96-4 |
度戈妥珠单抗
Duligotuzumab
3-5days
95+%
|
￥5000.00 |
— |
|
|
|
| CLA1295 |
|
1262787-83-6 |
帕曲妥单抗
Patritumab (Anti-ERBB3 / HER3)
3-5days
95+%
|
￥2500.00 |
— |
|
|
|
| CLA1240 |
|
725735-28-4 |
英妥木单抗
Intetumumab
3-5days
95+%
|
￥3500.00 |
— |
|
|
|
| CLA1221 |
|
906805-06-9 |
奈妥木单抗
Necitumumab (anti-EGFR)
3-5days
95+%
|
￥3000.00 |
— |
|
|
|
